Antiobesity Medication Use in 2.2 Million Adults Across Eight Large Health Care Organizations: 2009‐2015
David Saxon(University of Colorado Anschutz Medical Campus), Daniel H. Bessesen(Denver Health Medical Center), Caryn Oshiro(Kaiser Permanente Center for Health Research), Michael A. Horberg(Kaiser Permanente), Christie Mettenbrink(Denver Health Medical Center), David Arterburn(Kaiser Permanente Washington Health Research Institute), Deborah Rohm Young(Kaiser Permanente), Sean J. Iwamoto(University of Colorado Anschutz Medical Campus), Corinna Koebnick(Kaiser Permanente), Emily McCormick(Denver Public Health), Matthew F. Daley(Kaiser Permanente)
Cited by 148
Related Papers
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k
Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults With and Without HIV Infection, 2000-2016
|JAMA Network Open|2020|614
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
|MMWR Morbidity and Mortality Weekly Report|2021|602
Primary Care Guidelines for the Management of Persons Infected With HIV: 2013 Update by the HIV Medicine Association of the Infectious Diseases Society of America
|Clinical Infectious Diseases|2013|496
Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2016|441